Healthcare & Life Sciences
vTv Therapeutics
United Statesvtvtherapeutics.com/
vTv Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
2
Investors
About vTv Therapeutics
vTv Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
vTv Therapeutics is a late-stage biopharmaceutical company developing oral small molecule drugs, including cadisegliatin, a liver-selective glucokinase activator in Phase 3 trials as a potential oral adjunctive therapy for type 1 diabetes.
Explore vTv Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.